600285.SH
羚锐制药
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 19.58
+0.20%Aug 20, 2026, 22:22 UTC
As of August 20, 2026, more than 30 A-share listed companies disclosed securities firms among their top ten circulating shareholders in their 2026 semi-annual reports, with some firms increasing stakes and others newly appearing.
Source:Aug 11, 2026, 09:20 UTC
Lingrui Pharmaceutical disclosed its semi-annual report on August 11, reporting revenue of 2.148 billion yuan, up 2.32% year-on-year, and net profit attributable to shareholders of 495 million yuan, up 4.36% year-on-year.
Source: